ASE Technology (ASX) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
17 Jan, 2026Executive summary
Third quarter 2024 net revenues reached NT$160,105 million, up 14% sequentially and 3.9%-4% year-over-year, exceeding expectations due to strength in leading-edge advanced packaging and seasonal ramps in communications devices.
Net income attributable to shareholders was NT$9,666 million, up 24% quarter-over-quarter and 10% year-over-year.
Basic EPS was NT$2.24, a 24% increase from Q2 2024 and 10% higher than Q3 2023.
Equipment utilization was 65%-70% for both packaging and testing, with EMS demand slightly ahead of expectations due to earlier seasonality.
Financial highlights
Gross profit for Q3 2024 was NT$26,432 million with a gross margin of 16.5%, up 0.1 percentage points sequentially and 0.3 points year-over-year.
Operating profit reached NT$11,476 million, up TWD 2.5 billion sequentially and TWD 0.1 billion year-over-year, with an operating margin of 7.2%.
Net non-operating gain was NT$784 million, mainly from FX hedging and profits from associates.
EBITDA for the quarter was NT$28,621 million.
Excluding PPA expenses, net income attributable to shareholders was NT$10,835 million and basic EPS was NT$2.51.
Outlook and guidance
Leading-edge advanced packaging revenues expected to more than double in 2025, with over 10% of ATM revenue from leading-edge next year.
ATM Q4 revenues projected to grow slightly quarter-over-quarter, with gross margin flattish.
EMS Q4 revenues expected to decline mid-single digit quarter-over-quarter, with operating margin down 1 percentage point.
Margin improvement for next year expected to be back-end loaded due to front-end loaded investments.
Latest events from ASE Technology
- Strong 2025 results and robust 2026 outlook driven by AI, advanced packaging, and margin gains.ASX
Q4 20255 Feb 2026 - Q2 2024 net income rose to NT$7.8B on higher revenues and strong leading-edge demand.ASX
Q2 20243 Feb 2026 - Advanced packaging and testing drove 2024 growth, with strong 2025 outlook and major CapEx planned.ASX
Q4 20248 Jan 2026 - Q1 2025 net income up 33% year-over-year; ATM drives growth, EMS faces softness.ASX
Q1 202520 Dec 2025 - 7–9% revenue growth in H1/Q2 2025, led by advanced packaging and testing momentum.ASX
Q2 20256 Nov 2025 - Q3 2025 net income rose to NT$10,870 million on 11.8% sequential revenue growth, led by ATM.ASX
Q3 202530 Oct 2025